134 related articles for article (PubMed ID: 16187006)
1. Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients.
Lango R; Smoleński RT; Rogowski J; Siebert J; Wujtewicz M; Słomińska EM; Lysiak-Szydłowska W; Yacoub MH
Cardiovasc Drugs Ther; 2005 Aug; 19(4):267-75. PubMed ID: 16187006
[TBL] [Abstract][Full Text] [Related]
2. Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery.
Pastoris O; Dossena M; Foppa P; Catapano M; Arbustini E; Bellini O; Dal Bello B; Minzioni G; Ceriana P; Barzaghi N
Pharmacol Res; 1998 Feb; 37(2):115-22. PubMed ID: 9572066
[TBL] [Abstract][Full Text] [Related]
3. Effects of propionyl-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart.
Broderick TL; Paulson DJ; Gillis M
Drugs R D; 2004; 5(4):191-201. PubMed ID: 15230624
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
5. Propionyl-L-carnitine.
Wiseman LR; Brogden RN
Drugs Aging; 1998 Mar; 12(3):243-8; discussion 249-50. PubMed ID: 9534023
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
Pace S; Longo A; Toon S; Rolan P; Evans AM
Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure.
Anand I; Chandrashekhan Y; De Giuli F; Pasini E; Mazzoletti A; Confortini R; Ferrari R
Cardiovasc Drugs Ther; 1998 Jul; 12(3):291-9. PubMed ID: 9784909
[TBL] [Abstract][Full Text] [Related]
8. Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts.
Cui J; Das DK; Bertelli A; Tosaki A
Mol Cell Biochem; 2003 Dec; 254(1-2):227-34. PubMed ID: 14674702
[TBL] [Abstract][Full Text] [Related]
9. Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats.
Terada R; Matsubara T; Koh N; Nakamura J; Hotta N
Eur J Pharmacol; 1998 Sep; 357(2-3):185-91. PubMed ID: 9797035
[TBL] [Abstract][Full Text] [Related]
10. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
Brevetti G; Perna S; Sabbá C; Martone VD; Condorelli M
J Am Coll Cardiol; 1995 Nov; 26(6):1411-6. PubMed ID: 7594063
[TBL] [Abstract][Full Text] [Related]
11. Study on propionyl-L-carnitine in chronic heart failure.
Eur Heart J; 1999 Jan; 20(1):70-6. PubMed ID: 10075143
[TBL] [Abstract][Full Text] [Related]
12. Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium.
Cunningham VJ; Rosen SD; Boyd H; Osman S; Davenport RJ; Gunn RN; Pike VW; Camici PG
J Pharmacol Exp Ther; 1996 Apr; 277(1):511-7. PubMed ID: 8613961
[TBL] [Abstract][Full Text] [Related]
13. [The clinical and hemodynamic effects of propionyl-L-carnitine in the treatment of congestive heart failure].
Pucciarelli G; Mastursi M; Latte S; Sacra C; Setaro A; Lizzadro A; Nolfe G
Clin Ter; 1992 Nov; 141(11):379-84. PubMed ID: 1493661
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy.
Yang XP; Samaja M; English E; Benatti P; Tarantola M; Cardace G; Motterlini R; Micheletti R; Bianchi G
J Cardiovasc Pharmacol; 1992 Jul; 20(1):88-98. PubMed ID: 1383636
[TBL] [Abstract][Full Text] [Related]
15. Effect of propionyl-L-carnitine on experimental induced cardiomyopathy in rats.
Pasini E; Comini L; Ferrari R; de Giuli F; Menotti A; Dhalla NS
Am J Cardiovasc Pathol; 1992; 4(3):216-22. PubMed ID: 1298298
[TBL] [Abstract][Full Text] [Related]
16. The effect of preoperative L-carnitine supplementation on myocardial metabolism during aorto-coronary bypass surgery.
Böhles H; Noppeney T; Akcetin Z; Rein J; von der Emde J
Z Kardiol; 1987; 76 Suppl 5():14-8. PubMed ID: 3501644
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
[TBL] [Abstract][Full Text] [Related]
18. Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium.
Ferrari R; Di Lisa F; de Jong JW; Ceconi C; Pasini E; Barbato R; Menabò R; Barbieri M; Cerbai E; Mugelli A
J Mol Cell Cardiol; 1992 Mar; 24(3):219-32. PubMed ID: 1625347
[TBL] [Abstract][Full Text] [Related]
19. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
[TBL] [Abstract][Full Text] [Related]
20. Protection of isolated perfused working rat heart from oxidative stress by exogenous L-propionyl carnitine.
Ronca G; Ronca F; Yu G; Zucchi R; Bertelli A
Drugs Exp Clin Res; 1992; 18(11-12):475-80. PubMed ID: 1308473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
